MCRT Webcast: Myeloma Genetics with Three Experts
MC ROUND TABLES - September 22, 2020
Knowing about genetics is not just for scientists anymore. To be an informed myeloma patient it is essential to know what your specific genetic markers ar... Read More
Exercise and Mental Health
MUSCLES FOR MYELOMA - September 22, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
FDA Grants Orphan Drug Status to New CD38 Antibody Redirecting Molecule (ARM) Myeloma Therapy
FDA Grants Orphan Drug Status to New CD38 Antibody Redirecting Molecule (ARM) Myeloma Therapy
MYELOMA NEWS - September 18, 2020
The FDA has granted Orphan Drug designation to a new type of myeloma therapy called an Antibody Redirecting Molecule (ARM) targeting CD38. The orphan drug ... Read More
MRD Negativity is Better than Stringent Complete Response (sCR) to Determine Myeloma Patient Outcomes
MYELOMA NEWS - September 17, 2020
In a head-to-head study comparing minimal residual disease (MRD) testing vs. using the "stringent complete response" measurement, MRD indicated a more... Read More
Finding Balance with New Routines
LIFE WITH MYELOMA - September 17, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
HealthTree University: Starting Treatment (Part 2 of 3)
HEALTHTREE - September 17, 2020
There is so much to learn when you're starting myeloma treatment! How do you choose a transplant, induction therapy, consolidation therapy, maintenance ther... Read More
Financial Coach: Understanding Medicare And When To Shop Around For Best Coverage–Part 1
MYELOMA COACH - September 16, 2020
This is part one in a series of articles to assist you in preparing for Medicare enrollment and health insurance review. This article will be a refres... Read More
MGUS and Smoldering Myeloma: Register Now for the Myeloma Crowd Round Table Interactive Webcast on September 26
UPCOMING MC ROUND TABLES - September 15, 2020
MGUS and Smoldering Myeloma: Understanding Risk, Progression, and Clinical Trials Register Now Precursor conditions of myeloma may or ... Read More
Muscles for Myeloma: Low Intensity, Long Duration Exercise
MUSCLES FOR MYELOMA - September 15, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
New Ways to Use Our Own T Cells to Treat Myeloma
MYELOMA NEWS - September 14, 2020
Most of us have been reading about CAR-T treatments over the past few years to treat a variety of hematological malignancies. Two CAR-T products have been on th... Read More
Response Definitions After Myeloma Treatment
MYELOMA 101 - September 14, 2020
When your doctor tells you that your multiple myeloma is "in remission", what exactly does that mean? Myeloma experts divide patients into differ... Read More
Ninlaro with Dex and Revlimid Extends Survival for Newly Diagnosed, Transplant Ineligible Myeloma Patients
MYELOMA NEWS - September 11, 2020
New study results showed that the triplet combination including Ninlaro, lenalidomide and dex increased progression free survival for newly diagnosed myeloma pa... Read More
More Good News for Newly Diagnosed, High Risk Myeloma Patients
MYELOMA NEWS - September 11, 2020
Unfortunately, some of us are or have been tagged as high-risk myeloma patients (and I am one of them). There is some good news that has been reported from Germ... Read More
